PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34375763-10	2021	Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B.	Metformin	0-9	ataxin 7-like 3B	Mus musculus	30-38	
34375763-10	2021	Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B.	Metformin	0-9	ataxin 7-like 3B	Mus musculus	164-172	
34375763-10	2021	Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B.	Metformin	108-117	ataxin 7-like 3B	Mus musculus	30-38	
34375763-10	2021	Metformin treatment decreased ATXN7L3B-induced tumor-initiating ability in a HCC mouse model, implying that metformin may inhibit cancer stemness by downregulating ATXN7L3B.	Metformin	108-117	ataxin 7-like 3B	Mus musculus	164-172